Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Olin Corporation	OLN	10. oct 2024	42.15	+1.46
OLIVE RESOURCE CAPITAL	DFU	10. oct 2024	0.01	0.00
Ollies Bargain Outlet Holdings, Inc.	OL6	10. oct 2024	85.50	0.00
Olvi A	OVI	10. oct 2024	29.15	0.00
Olympic Steel, Inc.	OYS	10. oct 2024	35.80	+1.70
Olympus Corp.	OLY1	10. oct 2024	17.25	+0.20
OLYMPUS CORP. ADR	OLY	10. oct 2024	16.60	0.00
Oma Säästöpankki	OM0	10. oct 2024	13.90	+0.43
Omai Gold Mines Corp	0N2	10. oct 2024	0.10	+3.06
Omega Diagnostics Group Plc	RVKA	10. oct 2024	0.03	+3.39
Omega Healthcare Investors, Inc.	WX4	10. oct 2024	36.07	-0.33
OMEGA PACIFIC RESOURCES	Q0F	10. oct 2024	0.15	+20.66
Omer S.p.a	9WR	10. oct 2024	4.27	-2.29
Omer-Decugis & Cie	0VC	10. oct 2024	3.92	-1.01
Omeros Corporation	3O8	10. oct 2024	3.45	-0.75
Omni Bridgeway Limited	MXG1	10. oct 2024	0.67	0.00
Omnia Holdings Ltd	OHZ	10. oct 2024	3.28	-0.61
Omnicell, Inc.	OC9	10. oct 2024	38.20	-2.05
Omnicom Group Inc.	OCN	10. oct 2024	93.10	+0.24
OMV AG	OMVI	10. oct 2024	9.55	+0.53
OMV AG	OMV	10. oct 2024	39.28	+1.81
ON Semiconductor Corporation	XS4	10. oct 2024	63.80	-1.36
On the Beach Group plc	9BP	10. oct 2024	1.74	-0.57
Oncimmune Holdings plc	OCY	10. oct 2024	0.13	0.00
Oncoarendi Therapeutics SA	1B1	10. oct 2024	2.42	+0.83
ONCODES.PREC.MED. EO-,34	ZR8	10. oct 2024	1.22	+2.10
Onconova Therapeutics, Inc.	0T2	10. oct 2024	6.60	0.00
Oncopeptides	OND	10. oct 2024	0.17	-0.47
Oncotherpapy Science Inc	30O	10. oct 2024	0.19	-6.31
OncoZenge	8LY	10. oct 2024	0.61	+1.49

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.